Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling

BJU International

Volumn 108, Issue 11, 2011, Pages 1723-1727

  Taverna, Gianluigi ^a   Morandi, Giovanni ^b   Seveso, Mauro ^a   Giusti, Guido ^a   Benetti, Alessio ^a   Colombo, Piergiuseppe ^c   Minuti, Francesco ^d   Grizzi, Fabio ^a   Graziotti, Pierpaolo ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Division of Echography   (Italy)

^c Department of Pathology ^*  (Italy)

^d Service of Medical Statistics   (Italy)

Author keywords

biopsy; contrast agent; detection rate; prostate cancer; ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SONOVUE;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; GRAY SCALE ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; CONTRAST MEDIA; HUMANS; MALE; MICROBUBBLES; MIDDLE AGED; PHOSPHOLIPIDS; PROSTATE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 81255158832     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10199.x     Document Type: Article

References (27)

1. American Cancer Society. Cancer Facts and Figures. 2004. Atlanta: American Cancer Society, 2004
2. Aus G, Abbou CC, Bolla M, et al,. EAU guidelines on prostate cancer. Eur Urol 2005; 48: 546-51 (Pubitemid 41278578)
3. Djavan B, Margreiter M,. Biopsy standards for detection of prostate cancer. World J Urol 2007; 25: 11-7
4. Mitterberger M, Horninger W, Pelzer A, et al,. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guide biopsies: impact on prostate cancer detection. Prostate 2007; 67: 1537-42 (Pubitemid 47536152)
5. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J,. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006; 175: 1605-12
6. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ,. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000; 164: 388-92 (Pubitemid 30481932)
7. Dahnert WF, Hamper UM, Eggleston JC, Walsh PC,. Prostatic evaluation by transverse sonography with histopathologic correlation: echogenic appearance of early carcinoma. Radiology 1986; 158: 97-102 (Pubitemid 16169435)
8. Kirby RS,. Pre-treatment staging of prostate cancer: recent advances and future prospects. Prostate Cancer Prostatic Dis 1997; 1: 2-10 (Pubitemid 127537057)
9. Ismail M, Petersen RO, Alexander AA, Newschaffer C, Gomella LG,. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 1997; 50: 906-12 (Pubitemid 28021109)
10. Bogers HA, Sedelaar JP, Beerlage HP,. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54: 97-104 (Pubitemid 29323340)
11. Piscaglia F, Lencioni R, Sagrini E, et al,. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 2010; 36: 531-50
12. Stang A, Keles H, Hentschke S, et al,. Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 2009; 193: 709-21
13. Setola SV, Catalano O, Sandomenico F, Siani A,. Contrast-enhanced sonography of the kidney. Abdom Imaging 2007; 32: 21-8 (Pubitemid 46742685)
14. Fleischer AC, Lyshchik A, Andreotti RF, Hwang M, Jones HW III, Fishman DA,. Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles. AJR Am J Roentgenol 2010; 194: 343-8
15. Pallwewin L, Mitterberger M, Gradl J, et al,. Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Curr Opin Urol 2007; 17: 39-47 (Pubitemid 44901089)
16. Blomley M, Kiely P, Harvey CJ, Cosgrove D,. Microbubble contrast in trasrectal biopsy. Lancet 2001; 358: 1643-4
17. Kiely P, Butler-Barnes J, Blomley MJK, et al,. Transrectal biopsy of the prostate with infused microbubble contrast. Radiology 1998; 209: 1241
18. Sölétormos G, Semjonow A, Sibley PE, et al,. Biological variation of total prostate antigen: a survey of published estimates and consequences for clinical practice. Clin Chem 2005; 13: 1342-51 (Pubitemid 41060864)
19. Kaygisiz O, Ugurlu O, Kosan M, Inal G, Ozturk B, Cetinkaya M,. Effects of antibacterial teraphy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4-10 ng/ml. Prostate Cancer Prostatic Dis 2006; 9: 235-8 (Pubitemid 44317256)
20. Serretta V, Catanese A, Daricello G, et al,. PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients. Prostate Cancer Prostatic Dis 2008; 11: 148-52 (Pubitemid 351676603)
21. Hoekx L, Jeuris W, Van Marck E, Wyndaele JJ,. Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation. Acta Urol Belg 1998; 66: 1-2
22. Pelzer A, Bektic J, Berger AP, Frouscker F,. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 2005; 173: 1926-9 (Pubitemid 40675213)
23. Taverna GL, Maffezzini M, Benetti A, Seveso M, Giusti G, Graziotti P,. A single injection of lidocaine as local anesthesia for ultrasound guided needle biopsies of the prostate. J Urol 2002; 167: 222-3 (Pubitemid 34024537)
24. Egevad L, Norberg M, Mattson S, Nolrle BJ, Busch C,. Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy. Urology 1988; 52: 653-8
25. Stroumbakis N, Cookson MS, Reuter VE, Fair WR,. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology 1997; 49: 113-8 (Pubitemid 27133515)
26. Newman JS, Bree RL, Rubin JM,. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 1995; 195: 86-90
27. Bree RL,. The role of color Doppler and staging biopsies in prostate cancer detection. Urology 1997; 49: 31-4 (Pubitemid 27133507)